This study was undertaken to investigate the prevalence of coeliac disease
in children and adolescents with Turner syndrome. Eighty-seven children and
adolescents with Turner syndrome were screened for IgA-antiendomysium anti
bodies (EMA) and IgA-antigliadin antibodies (AGA), 5% (4/87) being found to
be EMA-positive, and 15% (13/87) to have AGA levels above normal. Of the 1
0 patients who were either AGA- or EMA-positive and further investigated wi
th intestinal biopsy, four manifested villous atrophy (i.e. all three of th
e EMA-positive patients, but only one of the seven AGA-positive patients).
The results suggest EMA-positivity to be a good immunological marker for us
e in screening for coeliac disease, and such screening to be justified in p
atients with Turner syndrome.